Technology | 2010.02.01
MabCure Featured in GenomeWeb
HASSELT, Belgium--(BUSINESS WIRE)--MabCure, Inc. (OTCBB:MBCI) (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in a January 14, 2010 article published on GenomeWeb, the largest online news organization focused on advanced research tools in genomics, proteomics, and bioinformatics. The cover story, written by Tony Fong and titled “MabCure Begins Clinic
For more information, please visit
http://www.businesswire.com/news/home/20100201005630/en
